Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction.
Level 5 - mechanism / opinion, no new human data
Narrative review detailing pathophysiological mechanisms and therapeutic options without systematic methodology or primary human data
PubMed 34439553 · doi:10.3390/antiox10081306
What was done
This narrative review synthesizes mechanistic and clinical literature regarding the pathophysiological links between diabetes mellitus, oxidative stress, and endothelial dysfunction, while summarizing how various hypoglycemic agents and antioxidant therapies influence endothelial health.
What was found
The abstract reports no numerical data or effect sizes. It details that chronic hyperglycemia and postprandial glucose fluctuations increase oxidative stress, while selective insulin resistance in the endothelial PI3K/Akt/eNOS pathway reduces nitric oxide (NO) production and increases endothelin-1. Hypoglycemic agents that limit glucose excursions (glinides, α-glucosidase inhibitors, DPP-4 inhibitors), improve insulin sensitivity (metformin, thiazolidinediones), or act via multiple pathways (GLP-1 receptor agonists, SGLT2 inhibitors) are expected to enhance endothelial function, whereas oral antioxidants are not recommended due to lack of clinical evidence.
Why it matters
The paper outlines mechanistic pathways by which distinct classes of diabetes medications may provide vascular protection beyond standard glycemic control, while cautioning against unproven oral antioxidant supplementation.
Limits
As a narrative review, it lacks systematic search methodology, quantitative pooling, and risk of bias assessment. The abstract reports no human sample sizes, trial details, or numerical outcome data.
Cited by
- supports Repeated, continuous spikes of glucose and insulin cause arterial plaque formation.